Repligen Corp (RGEN): Depreciation & Amortization
$78.75M
Year ended 2025-12-31
$78.78M
Trailing 12 months to 2026-06-30
+15.6%
3-year compound annual growth
+23.8%
5-year compound annual growth
+32.9%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $78.75M | +13.0% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $69.67M | +1.6% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $68.56M | +34.5% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $50.98M | +32.6% | 2025-03-14, From 2022-01-01 |
| 2021-12-31 | $38.45M | +42.0% | 2024-11-18, From 2021-01-01 |
| 2020-12-31 | $27.07M | +29.7% | 2023-02-22, From 2020-01-01 |
| 2019-12-31 | $20.87M | +32.3% | 2022-02-17, From 2019-01-01 |
| 2018-12-31 | $15.78M | +50.2% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $10.51M | +97.0% | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | $5.33M | +16.1% | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | $4.59M | +14.3% | 2018-02-22, From 2015-01-01 |
| 2014-12-31 | $4.02M | +29.1% | 2017-02-23, From 2014-01-01 |
| 2013-12-31 | $3.11M | -11.2% | 2016-02-25, From 2013-01-01 |
| 2012-12-31 | $3.51M | n/a | 2015-03-17, From 2012-01-01 |
| No annual figure between 2011-03-31 and 2012-12-31. | |||
| 2011-03-31 | $1.67M | +21.4% | 2013-03-15, From 2010-04-01 |
| 2010-03-31 | $1.38M | n/a | 2012-03-15, From 2009-04-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Repligen Corp (RGEN) | 2025-12-31 | $78.75M | +13.0% |
| BioCryst Pharmaceuticals Inc (BCRX) | 2025-12-31 | $1.39M | +11.5% |
| ADMA Biologics, Inc. (ADMA) | 2025-12-31 | $8.10M | +0.6% |
| Novavax Inc (NVAX) | 2025-12-31 | $27.61M | -43.1% |
| Bio-Techne Corp (TECH) | 2026-06-30 | $97.36M | -11.4% |
| Immunocore Holdings plc (IMCR) | 2025-12-31 | $3.10M | -26.2% |
| Halozyme Therapeutics, Inc. (HALO) | 2025-12-31 | $11.39M | +11.0% |
| Twist Bioscience Corp (TWST) | 2025-09-30 | $24.85M | -20.9% |
| Moderna, Inc. (MRNA) | 2025-12-31 | $211.00M | +14.1% |
Compare RGEN, BCRX, ADMA, NVAX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗